Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

15.2%

177 terminated/withdrawn out of 1166 trials

Success Rate

79.3%

-7.2% vs industry average

Late-Stage Pipeline

10%

112 trials in Phase 3/4

Results Transparency

51%

344 of 679 completed trials have results

Key Signals

187 recruiting344 with results126 terminated51 withdrawn

Enrollment Performance

Analytics

N/A

652(70.5%)

Phase 2

93(10.1%)

Phase 4

74(8.0%)

Phase 1

55(5.9%)

Phase 3

38(4.1%)

Early Phase 1

13(1.4%)

925Total

N/A(652)

Phase 2(93)

Phase 4(74)

Phase 1(55)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1166)

Showing 20 of 1166 trials

NCT07725523Phase 2Not Yet Recruiting

Safety and Efficacy of OTL78 (Zopocianine)

Role: collaborator

NCT07556341Not ApplicableRecruiting

Point-of-care Ultrasound Utility in the Free Clinic Setting

Role: lead

NCT03507257Active Not Recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Role: lead

NCT06982105Phase 4Recruiting

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

Role: lead

NCT06523985Not ApplicableActive Not Recruiting

The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution

Role: lead

NCT07191886Recruiting

Measuring Patient Reported Needs in Outpatient Liver Disease Management

Role: lead

NCT06396897Not ApplicableRecruiting

Hospital @ Home Model of Care for Cirrhosis

Role: lead

NCT04520698Not ApplicableCompleted

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Role: lead

NCT07679178Not ApplicableNot Yet Recruiting

Comparing Non-Medicine Strategies for Improving Low Back Pain

Role: collaborator

NCT06849544Phase 2Active Not Recruiting

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Role: collaborator

NCT04798014Completed

HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy

Role: lead

NCT05611307Recruiting

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Role: lead

NCT07727980Not ApplicableNot Yet Recruiting

Tissue Preservation in Immediate 1C Implants Using an Anatomical Prefabricated Healing Abutment

Role: collaborator

NCT05643144Not ApplicableRecruiting

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

Role: lead

NCT05079399Recruiting

Biomarker of Diabetic Retinopathy

Role: lead

NCT05856591Not ApplicableRecruiting

Delivering Food Resources & Kitchen Skills (FoRKS) to Adults With Food Insecurity and Hypertension

Role: lead

NCT07168785Early Phase 1Not Yet Recruiting

[18F]-AraG PET Imaging in LA HNSCC

Role: lead

NCT06152614Not ApplicableRecruiting

MIND Foods and Aerobic Training in Black Adults With HTN

Role: lead

NCT05826561Not ApplicableTerminated

Developing a Childhood Asthma Risk Passive Digital Marker

Role: lead

NCT03873259Not ApplicableRecruiting

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

Role: collaborator